ARTICLE | Clinical News
Risperdal depot risperidone: Completed Phase III trials
February 26, 2001 8:00 AM UTC
Alkermes Inc. (ALKS), Cambridge, Mass. Product: Risperdal depot risperidone Business: Neurological, Drug delivery Therapeutic category: Neurotransmission, Receptor antagonist Target: Dopamine Type 2 ...